Publication: Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques
| dc.contributor.author | Durdagi, Serdar | |
| dc.contributor.author | Salmas, Ramin Ekhteiari | |
| dc.contributor.author | Stein, Matthias Jeanette | |
| dc.contributor.author | Yurtsever, Mine | |
| dc.contributor.author | Seeman, Philip | |
| dc.contributor.institution | Durdagi, Serdar, Department of Biophysics, Bahçeşehir Üniversitesi, Istanbul, Turkey | |
| dc.contributor.institution | Salmas, Ramin Ekhteiari, Department of Biophysics, Bahçeşehir Üniversitesi, Istanbul, Turkey, Department of Chemistry, İstanbul Teknik Üniversitesi, Istanbul, Turkey | |
| dc.contributor.institution | Stein, Matthias Jeanette, Molecular Simulations and Design Group, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany | |
| dc.contributor.institution | Yurtsever, Mine, Department of Chemistry, İstanbul Teknik Üniversitesi, Istanbul, Turkey | |
| dc.contributor.institution | Seeman, Philip, Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada | |
| dc.date.accessioned | 2025-10-05T16:27:15Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | We have recently reported G-protein coupled receptor (GPCR) model structures for the active and inactive states of the human dopamine D2 receptor (D2R) using adrenergic crystal structures as templates. Since the therapeutic concentrations of dopamine agonists that suppress the release of prolactin are the same as those that act at the high-affinity state of the D2 receptor (D2High), D2High in the anterior pituitary gland is considered to be the functional state of the receptor. In addition, the therapeutic concentrations of anti-Parkinson drugs are also related to the dissociation constants in the D2High form of the receptor. The discrimination between the high- And low-affinity (D2Low) components of the D2R is not obvious and requires advanced computer-assisted structural biology investigations. Therefore, in this work, the derived D2High and D2Low receptor models (GPCR monomer and dimer three-dimensional structures) are used as drug-binding targets to investigate binding interactions of dopamine and apomorphine. The study reveals a match between the experimental dissociation constants of dopamine and apomorphine at their high- And low-affinity sites of the D2 receptor in monomer and dimer and their calculated dissociation constants. The allosteric receptor-receptor interaction for dopamine D2R dimer is associated with the accessibility of adjacent residues of transmembrane region 4. The measured negative cooperativity between agonist ligand at dopamine D2 receptor is also correctly predicted using the D2R homodimerization model. © 2017 Elsevier B.V., All rights reserved. | |
| dc.identifier.doi | 10.1021/acschemneuro.5b00271 | |
| dc.identifier.endpage | 195 | |
| dc.identifier.issn | 19487193 | |
| dc.identifier.issue | 2 | |
| dc.identifier.pubmed | 26645629 | |
| dc.identifier.scopus | 2-s2.0-84959354684 | |
| dc.identifier.startpage | 185 | |
| dc.identifier.uri | https://doi.org/10.1021/acschemneuro.5b00271 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14719/12532 | |
| dc.identifier.volume | 7 | |
| dc.language.iso | en | |
| dc.publisher | American Chemical Society service@acs.org | |
| dc.relation.source | ACS Chemical Neuroscience | |
| dc.subject.authorkeywords | D2high And D2low States Of Dopamine | |
| dc.subject.authorkeywords | Dopamine D2 Receptor | |
| dc.subject.authorkeywords | Gpcr Dimerization | |
| dc.subject.authorkeywords | Molecular Docking | |
| dc.subject.authorkeywords | Protein Engineering | |
| dc.subject.authorkeywords | Apomorphine | |
| dc.subject.authorkeywords | Dopamine | |
| dc.subject.authorkeywords | Apomorphine | |
| dc.subject.authorkeywords | Dopamine | |
| dc.subject.authorkeywords | Dopamine Agonists | |
| dc.subject.authorkeywords | Receptors, Dopamine D2 | |
| dc.subject.authorkeywords | Apomorphine | |
| dc.subject.authorkeywords | Dimer | |
| dc.subject.authorkeywords | Dopamine | |
| dc.subject.authorkeywords | Dopamine 2 Receptor | |
| dc.subject.authorkeywords | G Protein Coupled Receptor | |
| dc.subject.authorkeywords | Monomer | |
| dc.subject.authorkeywords | Dopamine Receptor Stimulating Agent | |
| dc.subject.authorkeywords | Protein Binding | |
| dc.subject.authorkeywords | Allosterism | |
| dc.subject.authorkeywords | Article | |
| dc.subject.authorkeywords | Binding Affinity | |
| dc.subject.authorkeywords | Chemical Structure | |
| dc.subject.authorkeywords | Dimerization | |
| dc.subject.authorkeywords | Dissociation Constant | |
| dc.subject.authorkeywords | Drug Binding Site | |
| dc.subject.authorkeywords | Drug Receptor Binding | |
| dc.subject.authorkeywords | Hydrogen Bond | |
| dc.subject.authorkeywords | Ligand Binding | |
| dc.subject.authorkeywords | Molecular Docking | |
| dc.subject.authorkeywords | Priority Journal | |
| dc.subject.authorkeywords | Protein Engineering | |
| dc.subject.authorkeywords | Protein Protein Interaction | |
| dc.subject.authorkeywords | Protein Structure | |
| dc.subject.authorkeywords | Stereospecificity | |
| dc.subject.authorkeywords | Three Dimensional Imaging | |
| dc.subject.authorkeywords | Binding Competition | |
| dc.subject.authorkeywords | Chemistry | |
| dc.subject.authorkeywords | Dose Response | |
| dc.subject.authorkeywords | Drug Effects | |
| dc.subject.authorkeywords | Human | |
| dc.subject.authorkeywords | Metabolism | |
| dc.subject.authorkeywords | Molecular Model | |
| dc.subject.authorkeywords | Procedures | |
| dc.subject.authorkeywords | Apomorphine | |
| dc.subject.authorkeywords | Binding, Competitive | |
| dc.subject.authorkeywords | Dopamine | |
| dc.subject.authorkeywords | Dopamine Agonists | |
| dc.subject.authorkeywords | Dose-response Relationship, Drug | |
| dc.subject.authorkeywords | Humans | |
| dc.subject.authorkeywords | Models, Molecular | |
| dc.subject.authorkeywords | Molecular Docking Simulation | |
| dc.subject.authorkeywords | Protein Binding | |
| dc.subject.authorkeywords | Protein Engineering | |
| dc.subject.authorkeywords | Receptors, Dopamine D2 | |
| dc.subject.indexkeywords | apomorphine | |
| dc.subject.indexkeywords | dimer | |
| dc.subject.indexkeywords | dopamine | |
| dc.subject.indexkeywords | dopamine 2 receptor | |
| dc.subject.indexkeywords | G protein coupled receptor | |
| dc.subject.indexkeywords | monomer | |
| dc.subject.indexkeywords | dopamine receptor stimulating agent | |
| dc.subject.indexkeywords | protein binding | |
| dc.subject.indexkeywords | allosterism | |
| dc.subject.indexkeywords | Article | |
| dc.subject.indexkeywords | binding affinity | |
| dc.subject.indexkeywords | chemical structure | |
| dc.subject.indexkeywords | dimerization | |
| dc.subject.indexkeywords | dissociation constant | |
| dc.subject.indexkeywords | drug binding site | |
| dc.subject.indexkeywords | drug receptor binding | |
| dc.subject.indexkeywords | hydrogen bond | |
| dc.subject.indexkeywords | ligand binding | |
| dc.subject.indexkeywords | molecular docking | |
| dc.subject.indexkeywords | priority journal | |
| dc.subject.indexkeywords | protein engineering | |
| dc.subject.indexkeywords | protein protein interaction | |
| dc.subject.indexkeywords | protein structure | |
| dc.subject.indexkeywords | stereospecificity | |
| dc.subject.indexkeywords | three dimensional imaging | |
| dc.subject.indexkeywords | binding competition | |
| dc.subject.indexkeywords | chemistry | |
| dc.subject.indexkeywords | dose response | |
| dc.subject.indexkeywords | drug effects | |
| dc.subject.indexkeywords | human | |
| dc.subject.indexkeywords | metabolism | |
| dc.subject.indexkeywords | molecular model | |
| dc.subject.indexkeywords | procedures | |
| dc.subject.indexkeywords | Apomorphine | |
| dc.subject.indexkeywords | Binding, Competitive | |
| dc.subject.indexkeywords | Dopamine | |
| dc.subject.indexkeywords | Dopamine Agonists | |
| dc.subject.indexkeywords | Dose-Response Relationship, Drug | |
| dc.subject.indexkeywords | Humans | |
| dc.subject.indexkeywords | Models, Molecular | |
| dc.subject.indexkeywords | Molecular Docking Simulation | |
| dc.subject.indexkeywords | Protein Binding | |
| dc.subject.indexkeywords | Protein Engineering | |
| dc.subject.indexkeywords | Receptors, Dopamine D2 | |
| dc.title | Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques | |
| dc.type | Article | |
| dcterms.references | Audet, Martin, Restructuring G-Protein- Coupled Receptor Activation, Cell, 151, 1, pp. 14-23, (2012), Dror, Ron O., Activation mechanism of the β 2-adrenergic receptor, Proceedings of the National Academy of Sciences of the United States of America, 108, 46, pp. 18684-18689, (2011), Rosenbaum, Daniel M., Structure and function of an irreversible agonist-β2 adrenoceptor complex, Nature, 469, 7329, pp. 236-242, (2011), McDonald, William M., Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors, Molecular and Cellular Endocrinology, 36, 3, pp. 201-209, (1984), George, Susan R., The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form, Endocrinology (United States), 117, 2, pp. 690-697, (1985), Seeman, Philip, Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2High receptors, Synapse, 61, 12, pp. 1013-1018, (2007), Seeman, Philip, Dopamine Receptor Parameters Detected by [3H]Spiperone Depend on Tissue Concentration: Analysis and Examples, Journal of Neurochemistry, 43, 1, pp. 221-235, (1984), Seeman, Philip, Deriving the therapeutic concentrations for clozapine and haloperidol: The apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand, European Journal of Pharmacology - Molecular Pharmacology Section, 291, 2, pp. 59-66, (1995), Seeman, Philip, Dopamine D2 receptor binding sites for agonists: A tetrahedral model, Molecular Pharmacology, 28, 5, pp. 391-399, (1985), Seeman, Philip, Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography, Synapse, 49, 4, pp. 209-215, (2003) | |
| dspace.entity.type | Publication | |
| local.indexed.at | Scopus | |
| person.identifier.scopus-author-id | 22955598300 | |
| person.identifier.scopus-author-id | 56338023600 | |
| person.identifier.scopus-author-id | 7402996760 | |
| person.identifier.scopus-author-id | 56067383000 | |
| person.identifier.scopus-author-id | 36045322000 |
